Bio-Rad Laboratories (BIO)
Health Care · Life science instrumentation and clinical diagnostics
A multinational life science and clinical diagnostics company providing research tools, diagnostic test systems, and consumables to laboratories and biopharmaceutical manufacturers worldwide.
What Bio-Rad Laboratories does
Bio-Rad Laboratories develops, manufactures, and markets instruments, systems, reagents, and consumables for life science research and clinical diagnostics. The company operates in two segments: Life Science (40% of sales), serving research labs and biopharmaceutical manufacturing, and Clinical Diagnostics (60% of sales), providing in vitro diagnostic test systems and reagents for clinical laboratories. With operations in over 36 countries, Bio-Rad generates roughly 40% of revenue domestically and 60% internationally.
Themes: ["Life science research tools","In vitro diagnostics (IVD)","Clinical laboratory workflows","Biopharmaceutical manufacturing support","Quality control and testing"]
Fundamentals
- Price$297.28 as of 2026-07-09 close
- Market cap$7.9B as of 2026-07-10
- 1-year return+17.5% as of 2026-07-09 close
- P/E46.99 as of 2026-07-10
- Net margin+6.5% as of 2026-07-10
- Gross margin+51.8% as of 2026-07-10
- ROE+2.4% as of 2026-07-10
- Debt / equity0.18 as of 2026-07-10
- Revenue growth (YoY)+1.9% as of 2026-07-10
- Revenue CAGR (3y)-2.7% SEC XBRL
- Beta1.07 as of 2026-07-10
Key risks (from latest filing)
["International operations exposure to geopolitical conditions, tariffs, trade barriers, and foreign currency fluctuations","Dependency on government funding and capital spending from research customers; vulnerability to reductions in such spending","Supply chain disruptions and reliance on sole-source suppliers for certain components and materials"]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.